ASR Vermogensbeheer N.V. Reduces Holdings in Mettler-Toledo International, Inc. $MTD

ASR Vermogensbeheer N.V. trimmed its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 0.5% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,144 shares of the medical instruments supplier’s stock after selling 20 shares during the quarter. ASR Vermogensbeheer N.V.’s holdings in Mettler-Toledo International were worth $4,868,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in MTD. Vanguard Group Inc. boosted its position in shares of Mettler-Toledo International by 1.2% during the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier’s stock valued at $3,003,485,000 after buying an additional 30,535 shares during the period. Alliancebernstein L.P. boosted its position in shares of Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after buying an additional 126,147 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in Mettler-Toledo International by 5.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock valued at $568,032,000 after acquiring an additional 25,272 shares during the period. T. Rowe Price Investment Management Inc. boosted its holdings in Mettler-Toledo International by 11.9% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier’s stock valued at $479,673,000 after acquiring an additional 43,082 shares during the period. Finally, PineStone Asset Management Inc. boosted its holdings in Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after acquiring an additional 98,737 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Up 1.1%

Shares of NYSE:MTD opened at $1,314.48 on Friday. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,486.76. The stock has a market cap of $27.08 billion, a price-to-earnings ratio of 33.29, a PEG ratio of 3.90 and a beta of 1.37. The business has a 50-day moving average price of $1,272.23 and a 200-day moving average price of $1,186.35.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same period last year, the firm posted $9.65 EPS. Mettler-Toledo International’s revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, equities analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at $6,389,588.55. The trade was a 5.56% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider directly owned 94 shares of the company’s stock, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,827 shares of company stock worth $2,371,208. 1.94% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

MTD has been the subject of a number of recent analyst reports. Robert W. Baird boosted their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Evercore ISI lowered their price objective on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating for the company in a research report on Monday, August 4th. Barclays boosted their price target on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a report on Thursday. Bank of America boosted their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Mettler-Toledo International in a report on Saturday, September 27th. Five analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $1,328.33.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.